OPEN END TURBO OPTIONSSCHEIN SHORT - COOPER COMPANIES Share Price

Certificat

DE000GG7EEB2

Real-time BOERSE MUENCHEN 19:35:40 22/05/2024 BST
0.042 EUR -2.33% Intraday chart for OPEN END TURBO OPTIONSSCHEIN SHORT - COOPER COMPANIES
Current month-56.25%
Date Price Change
22/05/24 0.042 -2.33%
21/05/24 0.043 +13.16%
20/05/24 0.038 -2.56%
17/05/24 0.039 +8.33%
15/05/24 0.036 -26.53%

Real-time BOERSE MUENCHEN

Last update May 22, 2024 at 07:35 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying THE COOPER COMPANIES, INC.
Issuer Goldman Sachs
WKN GG7EEB
ISINDE000GG7EEB2
Date issued 23/04/2024
Strike 99.25 $
Maturity Unlimited
Parity 100 : 1
Emission price 0.09
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.102
Lowest since issue 0.036

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
96.6 USD
Average target price
107.9 USD
Spread / Average Target
+11.69%
Consensus